BernhardJosefHeringMD
Internal Medicine • Minneapolis, MNProfessor, Surgery, University of Minnesota Medical School. Preventative Cardiology
Are you Dr. Hering?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 10 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
516 Delaware Street SE
PWB First floor Clinic 1e UNIV of Minn Physicians
Minneapolis, MN 55455Phone+1 612-626-6666Fax+1 612-625-8496- Is this information wrong?
Summary
- Dr. Bernhard Hering, MD is an internist in Minneapolis, Minnesota. He is currently licensed to practice medicine in Minnesota. He is affiliated with M Health Fairview University of Minnesota Medical Center and is a Professor at University of Minnesota Medical School. Preventative Cardiology.
Education & Training
University of Giessen Faculty of MedicineClass of 1983
Certifications & Licensure
MN State Medical License 1998 - 2025
Clinical Trials
- MGA031, Sirolimus and Tacrolimus in Islet Transplantation Start of enrollment: 2005 Nov 01
- hOKT3γ1 (Ala-Ala) Combined With Sirolimus and Delayed Tacrolimus in Type 1 Diabetic Islet Allograft Recipients Start of enrollment: 2000 Apr 01
- Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type 1 Diabetes Start of enrollment: 2000 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Peri-Transplant Inflammation and Long-Term Diabetes Outcomes Were Not Impacted by Either Etanercept or Alpha-1-Antitrypsin Treatment in Islet Autotransplant Recipients.Hodges, J., Abdel-Karim, T., Herold, K., Pruett, T., Ramanathan, K., Hering, B., Dunn, T., Kirchner, V., Beilman, G., Bellin, M.> ;Transplant International. 2024 Jan 1
- Early Metabolic Measures Predict Long-term Insulin Independence in Recipients of Total Pancreatectomy and Islet Autotransplantation.Nanno, Y., Hodges, J., Freeman, M., Schwarzenberg, S., Downs, E., Trikudanathan, G., Ramanathan, K., Pruett, T., Beilman, G., Chinnakotla, S., Hering, B., Bellin, M.> ;Transplantation Direct. 2024 Jan 1
- 11 citationsFactors associated with favourable 5 year outcomes in islet transplant alone recipients with type 1 diabetes complicated by severe hypoglycaemia in the Collaborative I...Bernhard J Hering, Cassandra M Ballou, Melena D Bellin, Elizabeth H Payne, Fouad Kandeel, Piotr Witkowski, Rodolfo Alejandro, Michael R Rickels, Franca B Barton> ;Diabetologia. 2023 Jan 1
- Join now to see all
Press Mentions
Penn Study Proves Promising for Type 1 Diabetes CureSeptember 14th, 2020- Penn Researchers Advance Potential Cure for Type 1 DiabetesSeptember 8th, 2020
Researchers Remove the Need for Anti-Rejection Drugs in Transplant RecipientsAugust 5th, 2019- Join now to see all
Grant Support
- Efalizumab (RAPTIVA) Combined With Sirolimus In Type 1 Diabetic Islet AllograftNational Center For Research Resources2009
- Clinical Trial: Hokt3g1 (Ala-Ala), Sirolimus And Low Dose Tacrolimus Therapy InNational Center For Research Resources2009
- PIG To Non-Human Primate Islet XenograftsNational Institute Of Allergy And Infectious Diseases2008–2009
- Cit-03: Single-Center, Open-Label Clinical Trial Of The Efficacy Of PeritransplaNational Center For Research Resources2007–2009
- Screening Procedure For Allo-Islet Transplantation ProtocolsNational Center For Research Resources2006–2009
- Clinical Trial: Hokt3Î|1 (Ala-Ala), Sirolimus And Low Dose Tacrolimus TheraNational Center For Research Resources2008
- Human Pancreatic Islet Cell ResourcesNational Center For Research Resources2006–2008
- Advancing Islet Transplants For Type 1 Diabetes CareNational Institute Of Allergy And Infectious Diseases2004–2008
- Cts-Ipita-Ixa 2007 Joint ConferenceNational Institute Of Allergy And Infectious Diseases2007
- Hokt3γ1 (Ala-Ala), Sirolimus And Low Dose Tacrolimus Therapy In Type 1 DiabNational Center For Research Resources2007
- Islet Transplantation In Type 1 Diabetic Patients Using The Edmonton ProtocolNational Center For Research Resources2004–2007
- Anti-Thymoglobumlin, Cyclosporin And RAD In Islet TransplantNational Center For Research Resources2004–2007
- Preclinical Models Of Organ &Cell Transplant ToleranceNational Institute Of Diabetes And Digestive And Kidney Diseases2006
- Mixed Chimerism In Haploidentical Non-Human PrimatesNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2006
- Human Pancreatic Islet Cell Resources (ICRS)National Center For Research Resources2001–2006
- Initial VS Delayed Mycophenolate Mofetil In Single-Donor Islet AllotransplantatNational Center For Research Resources2005
- Human Pancreatic Islet Cell Resources Type 1 DiabetesNational Center For Research Resources2004–2005
- Hokt3gammal (Ala-Ala) For The Prevention Of Human Islet Allograft FailureNational Center For Research Resources2004–2005
- Tolerance To Islet Allografts In Type I DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2005
- Initial Vs. Delayed Mycophenolate Mofetil In Single-Donor Islet AllotransplantanNational Center For Research Resources2004
- Immunotherapy And Islet Replacement In Early DiabetesNational Center For Research Resources2000–2002
Hospital Affiliations
M Health Fairview University of Minnesota Medical CenterMinneapolis, Minnesota
